Algenist Sold Fake Collagen to Consumers Nationwide
Algenist marketed its GENIUS line cosmetics as containing collagen, an expensive anti-aging ingredient. Instead, the products contained cheap plant proteins derived from corn, soy, and wheat. Consumers paid premium prices for fake ingredients.
Algenist LLC sold three skincare products labeled as containing collagen, a sought-after animal protein known for anti-aging benefits. The products actually contained plant-based substitutes made from corn, soy, and wheat. Consumers paid premium prices believing they were purchasing genuine collagen. The company used cheaper ingredients while charging higher prices, misleading millions of buyers nationwide.
If you purchased Algenist GENIUS collagen products, you may be entitled to compensation.
The Allegations: A Breakdown
| 01 | Algenist prominently labeled three GENIUS products as containing collagen on front packaging. The products do not contain any actual collagen. Instead, they contain plant proteins from corn, soy, and wheat. | high |
| 02 | Algenist acknowledged on its website that its plant-based compound is formulated to provide a functional and structural equivalent to animal-derived collagen. The company admits the products contain imitation collagen, not the real ingredient consumers expect. | high |
| 03 | Real collagen is an animal protein found exclusively in connective tissues of animals, including skin, bones, and cartilage. Collagen does not exist in plants. Algenist sold plant proteins while using the collagen label. | high |
| 04 | Manufacturing genuine collagen, especially marine collagen, costs significantly more due to complex raw material procurement, extraction, and quality control processes. Algenist saved substantial production costs by using cheap corn, soy, and wheat proteins instead. | high |
| 05 | Consumers paid a substantial price premium for Algenist products based on the collagen representations. Plaintiff Adelina Pepenella and millions of others relied on these front-label claims when choosing Algenist over competing products. | high |
| 06 | Other comparable cosmetics that represent collagen on their labels actually contain genuine animal-sourced collagen. Algenist deceived consumers by using the same labeling practices as competitors while substituting fake ingredients. | medium |
| 07 | The collagen market exploded from $3.5 billion in 2018 to $8.36 billion in 2020, driven by consumer demand for anti-aging benefits. Algenist capitalized on this trend by falsely marketing plant proteins as collagen to maximize profits. | high |
| 08 | Consumers with allergies to soy, wheat, or corn face potential health risks. The prominent collagen labeling may cause these buyers to overlook allergen disclosures hidden in fine print, creating safety concerns. | medium |
| 01 | Algenist substituted expensive animal collagen with cheap plant proteins to increase profit margins. This substitution allowed the company to charge premium prices while spending far less on actual ingredients. | high |
| 02 | The production costs for corn, soy, and wheat fiber collagen substitutes are substantially lower than costs for genuine animal collagen manufacturing. Algenist pocketed the difference while consumers overpaid for inferior products. | high |
| 03 | Algenist continued selling these misleadingly labeled products for years. The company maintained its deceptive labeling practices throughout the applicable statute of limitations period, showing ongoing profit prioritization. | high |
| 04 | The company is owned by Tengram Capital Partners LP, a Connecticut-based private equity firm. Corporate ownership structure suggests profit maximization incentives drove the misleading marketing strategy. | medium |
| 05 | Algenist sells products both online and through retail stores nationwide. The widespread distribution amplified profits from the deceptive labeling scheme while harming consumers across all 50 states. | medium |
| 06 | The lawsuit alleges Algenist continues to be unjustly enriched at consumer expense. The company retains profits from years of misleading sales while consumers received products worth far less than advertised. | high |
| 01 | Plaintiff Adelina Pepenella purchased multiple Algenist products in February 2024 at a New York cosmetic store. She paid premium prices based on the collagen representations and would not have purchased the products on the same terms had she known the truth. | high |
| 02 | Class members number in the millions nationwide. These consumers collectively paid inflated prices for products that did not contain the premium ingredient they believed they were purchasing. | high |
| 03 | Consumers lost money on every purchase. They paid for genuine collagen but received cheap plant protein substitutes, suffering economic injury on each transaction involving the misbranded products. | high |
| 04 | The price premium consumers paid represents a significant cost saving for Algenist. The gap between genuine collagen costs and plant protein costs went directly to corporate profits rather than product quality. | high |
| 05 | Local retailers who carried Algenist products face potential reputation damage. Small businesses that stocked these items may lose customer trust and face indirect economic harm from the deceptive labeling controversy. | medium |
| 06 | Consumers seeking actual collagen benefits did not receive them. Buyers lost both their money and the opportunity to purchase genuine collagen products that might have delivered the anti-aging results they sought. | medium |
| 07 | The class action seeks recovery of actual damages, statutory damages, punitive damages, and attorney fees. The total economic impact likely exceeds $5 million based on nationwide sales and premium pricing over multiple years. | high |
| 01 | Consumers with corn, soy, or wheat allergies face potential allergic reactions. The prominent collagen labeling may lead these individuals to overlook crucial allergen information buried in ingredient lists. | high |
| 02 | Front-label emphasis on collagen overshadows more important safety disclaimers. Allergic consumers may fail to identify dangerous ingredients because they trust the misleading collagen representation on packaging. | high |
| 03 | Plant-based proteins do not provide the same structural benefits as genuine animal collagen. Consumers seeking specific anti-aging or skin health results may not achieve their health goals due to ingredient substitution. | medium |
| 04 | Misleading labeling undermines public health by corrupting marketplace trust. When consumers cannot rely on product labels, they lose ability to make informed health and safety decisions about cosmetics and skincare. | medium |
| 05 | Consumers looking for scientifically validated collagen products may fail to address their cosmetic concerns. The fake collagen wastes consumer money while leaving genuine skin health needs unmet. | medium |
| 01 | Algenist conducts substantial business throughout New York and the United States. Despite nationwide operations, the company marketed systematically misleading products without effective regulatory intervention. | high |
| 02 | The lawsuit alleges violations of consumer protection statutes in dozens of states. Algenist allegedly violated laws across Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, and more than 35 other jurisdictions. | high |
| 03 | The company violated New York General Business Law sections 349 and 350, which prohibit deceptive practices and false advertising. These violations occurred in the conduct of business and trade throughout New York state. | high |
| 04 | Algenist formulates, manufactures, advertises, and sells the misleading products. The company controls every stage from production to marketing, demonstrating systematic rather than accidental deception. | high |
| 05 | Corporate ownership structure includes both Algenist LLC and parent company Tengram Capital Partners LP. Both entities are named as defendants and allegedly acted as authorized agents in the deceptive marketing scheme. | medium |
| 06 | The deceptive conduct is consumer-directed and materially misleading. The misrepresentations fundamentally distort the nature and value of the products, constituting the type of harm consumer protection laws exist to prevent. | high |
| 07 | Algenist likely retained benefits from wrongdoing absent class action intervention. Without collective legal action, the company would keep profits from years of misleading sales with no accountability. | high |
| 01 | Algenist prominently displays collagen on all three GENIUS product labels. The company uses large, eye-catching text and repeated collagen references to create the impression consumers are buying genuine collagen. | high |
| 02 | Product names include GENIUS Sleeping Collagen, GENIUS Liquid Collagen Essence, and GENIUS Liquid Collagen. The collagen term appears in every product name, making the deception central to brand identity and marketing. | high |
| 03 | Algenist describes its ingredient as Active Vegan Collagen on its website. This marketing language creates the false impression that vegan collagen exists as a genuine alternative when collagen is by definition an animal protein. | high |
| 04 | The company markets products as best sellers on its website. Algenist leverages popularity claims to further boost sales of the misleadingly labeled collagen products to unsuspecting consumers. | medium |
| 05 | Ingredient lists bury the truth in fine print while front labels scream collagen. The packaging design ensures consumers see the misleading collagen claim while the actual plant protein ingredients remain hidden in dense text. | high |
| 06 | Algenist sells products both online and through third-party retailers nationwide. The multi-channel distribution strategy maximizes consumer exposure to the deceptive labeling across shopping contexts. | medium |
| 01 | Algenist sold millions of dollars worth of fake collagen products to consumers nationwide. The systematic mislabeling represents a corporate decision to prioritize profits over truthful marketing and consumer trust. | high |
| 02 | Consumers paid premium prices for cheap plant proteins marketed as expensive collagen. The price difference went straight to corporate profits while buyers received products worth far less than advertised. | high |
| 03 | The class action seeks to recover damages for all affected consumers. Plaintiff Adelina Pepenella represents a nationwide class and New York subclass of millions who purchased the misleadingly labeled products. | high |
| 04 | This case demonstrates how weak oversight enables corporate deception. Without class action lawsuits bringing misconduct to light, companies like Algenist face little accountability for misleading marketing practices. | high |
| 05 | The lawsuit demands compensatory damages, statutory damages, punitive damages, and attorney fees. Courts must hold corporations accountable when they systematically mislead consumers for profit. | high |
| 06 | Consumer awareness and legal action remain vital tools against corporate misconduct. Only through collective action can ordinary buyers counter the vast resources corporations deploy to defend deceptive practices. | medium |
Timeline of Events
Direct Quotes from the Legal Record
“its plant-based compound is formulated to provide a functional and structural equivalent to animal-derived collagen”
π‘ Algenist acknowledges on its own website that products do not contain real collagen but rather plant-based substitutes designed to mimic it.
“Algenist markets its Products in a systematically misleading manner by conspicuously misrepresenting on the Products’ front labels that they contain collagen”
π‘ The lawsuit establishes that prominent front-label claims led consumers to believe they were purchasing genuine collagen products.
“the Products use a fake imitation of collagen derived entirely from corn, soy and wheat plant protein fibers”
π‘ Algenist substituted cheap plant proteins for expensive animal collagen while maintaining premium pricing and misleading labels.
“Collagen is an animal protein found primarily in the connective tissues of animals, including their skin, bones, and cartilage. Collagen is not found in plants.”
π‘ The scientific definition makes clear that Algenist’s use of collagen labeling for plant-based products constitutes fundamental misrepresentation.
“Manufacturing collagen, particularly marine collagen, is notably more expensive due to the complex processes involved in raw material procurement, extraction, and rigorous quality control measures”
π‘ The cost difference between genuine collagen and plant substitutes reveals Algenist’s financial motive for the deceptive labeling scheme.
“the production costs for corn, soy, and wheat fiber collagen are substantially lower than those associated with genuine animal collagen manufacturing”
π‘ Algenist increased profit margins by using cheap ingredients while charging premium prices based on false collagen representations.
“Plaintiff Pepenella paid a substantial price premium due to Algenist’s false and misleading representations concerning the Products”
π‘ The price premium shows concrete economic harm suffered by plaintiff and millions of class members who overpaid for misrepresented products.
“Plaintiff Pepenella relied on Algenist’s representations when she decided to purchase the Products over comparable products that did not make those claims”
π‘ The reliance element establishes that deceptive labeling directly caused consumer purchasing decisions and economic injury.
“she would not have purchased the Products on the same terms had she known that those representations were not true”
π‘ This demonstrates but-for causation between Algenist’s deception and consumer harm, establishing basis for damages.
“similar cosmetics representing collagen do, in fact, contain the genuine animal-sourced ingredient”
π‘ Competitor products prove that collagen labeling creates consumer expectation of genuine animal-derived collagen, making Algenist’s substitution deceptive.
“Consumers with allergies to soy, wheat, or corn could be at risk if they believe they are purchasing an animal-based collagen product”
π‘ The misleading collagen label creates safety risks by causing allergic consumers to overlook dangerous plant protein ingredients in fine print.
“sales of collagen more than doubled between 2018 and 2020 and are expected to reach over $16 billion by 2028”
π‘ The exploding market created financial incentive for Algenist to capitalize on collagen demand with cheaper fake substitutes while maintaining premium pricing.
“Algenist is, and continues to be, unjustly enriched at the expense of their consumers”
π‘ The ongoing enrichment shows Algenist continues profiting from deceptive practices rather than correcting misleading labels or compensating harmed consumers.
“The Consumer Protection Statutes of the Nationwide Class members prohibit the use of deceptive, unfair, and misleading business practices”
π‘ Algenist violated consumer protection laws across all 50 states, demonstrating nationwide scope of systematic misconduct.
“members of the Classes number in the millions”
π‘ The massive class size reveals the scale of Algenist’s deception and the total economic harm inflicted on consumers nationwide.
Frequently Asked Questions
π‘ Explore Corporate Misconduct by Category
Corporations harm people every day β from wage theft to pollution. Learn more by exploring key areas of injustice.
- π Product Safety Violations β When companies risk lives for profit.
- πΏ Environmental Violations β Pollution, ecological collapse, and unchecked greed.
- πΌ Labor Exploitation β Wage theft, worker abuse, and unsafe conditions.
- π‘οΈ Data Breaches & Privacy Abuses β Misuse and mishandling of personal information.
- π΅ Financial Fraud & Corruption β Lies, scams, and executive impunity.